Article
Original Article

Baldua V.* , Castellino N.* , Kadam P.* , Avasthi B.** , Kabra N.***

*PICU , **Department of Paediatrics and PICU, ***Chief : Critical Care Units Surya Children’s Hospital, Mumbai

 

Corresponding author:

Dr. Vishal Baldua Surya Children`s Hospital , Santacruz West , Mumbai 400 054 vishalbaldua@gmail.com 

Year: 2016, Volume: 6, Issue: 1, Page no. 14-24,
Views: 535, Downloads: 3
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Introduction: In the diagnosis and management of sepsis, culture positivity yield is quite low and no single biomarker can diagnose sepsis early and reliably .

Aim & Objective: To compare the roles of Procalcitonin (PCT) and C - reactive protein (CRP) in the diagnosis of paediatric sepsis .

Methods: This prospective observational study was conducted between February 2014 to December 2014 at the tertiary level Paediatric Intensive Care Unit at Surya Children's Hospital, Mumbai. All patients admitted in PICU with suspected sepsis whose CBC, CRP, Procalcitonin and blood cultures were sent prior to initiation of antibiotics or escalation of existing antibiotics in case of new or worsening signs ,were included .

Results: Out of 89 children matching the inclusion criteria, 60 (67.4%) had positive CRP values (>6mg/dl) while 50(56.2%) were PCT positive. 10 (11.2%)of these had PCT between 0.5 and 2 ng/ml and remaining 40(45%)had levels more than 2mg/ml of PCT. The sensitivity and specificity of CRP was 89% and 35% respectively. At cut-off of 0.5ng/ml, sensitivity of PCT was 100% but the specificity was only 48%. This improves at a higher PCT of more than 2ng/ml to 88.9% and 60% respectively. Blood cultures were positive in only 9 cases and may be attributed to prior antibiotic usage .

Conclusion: PCT at cut-offs of >2ng/ml may be a better biomarker than CRP which is commonly used . Larger multicentric pediatric trials are needed and PCT may help rationalize antibiotic usage and duration in pediatric sepsis similar to some evolving practices in adult ICUs.

<p><strong>Introduction: </strong>In the diagnosis and management of sepsis, culture positivity yield is quite low and no single biomarker can diagnose sepsis early and reliably .</p> <p><strong>Aim &amp; Objective: </strong>To compare the roles of Procalcitonin (PCT) and C - reactive protein (CRP) in the diagnosis of paediatric sepsis .</p> <p><strong>Methods: </strong>This prospective observational study was conducted between February 2014 to December 2014 at the tertiary level Paediatric Intensive Care Unit at Surya Children's Hospital, Mumbai. All patients admitted in PICU with suspected sepsis whose CBC, CRP, Procalcitonin and blood cultures were sent prior to initiation of antibiotics or escalation of existing antibiotics in case of new or worsening signs ,were included .</p> <p><strong>Results:</strong> Out of 89 children matching the inclusion criteria, 60 (67.4%) had positive CRP values (&gt;6mg/dl) while 50(56.2%) were PCT positive. 10 (11.2%)of these had PCT between 0.5 and 2 ng/ml and remaining 40(45%)had levels more than 2mg/ml of PCT. The sensitivity and specificity of CRP was 89% and 35% respectively. At cut-off of 0.5ng/ml, sensitivity of PCT was 100% but the specificity was only 48%. This improves at a higher PCT of more than 2ng/ml to 88.9% and 60% respectively. Blood cultures were positive in only 9 cases and may be attributed to prior antibiotic usage .</p> <p><strong>Conclusion: </strong>PCT at cut-offs of &gt;2ng/ml may be a better biomarker than CRP which is commonly used . Larger multicentric pediatric trials are needed and PCT may help rationalize antibiotic usage and duration in pediatric sepsis similar to some evolving practices in adult ICUs.</p>
Keywords
C-reactive protein, Procalcitonin, Blood culture, sepsis
Downloads
  • 1
    FullTextPDF
Article

None

Supporting File
No Pictures
References

None

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.